semaglutide microdosing Noom to Sell Microdoses of Wegovy Is Microdosing Ozempic and GLP-1

FDA-APPROVED INDICATIONS Type 2 diabetes As an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus Limitations of use: has not been studied in patients with a history of pancreatitis TYPE 2 DIABETES RCT SURPASS-2 trial - Tirzepatide vs Semaglutide in Patients with Type 2 Diabetes, NEJM (2021) [PubMed abstract] The SURPASS-2 trial enrolled 1879 adults with type 2 diabetes who were inadequately controlled with metformin at a dose of at least 1500 mg per day Main inclusion criteria Age 18 years T2DM uncontrolled with metformin at 1500 mg/day A1C of 7 - 10.5% BMI 25 and stable for 3 months Main exclusion criteria Type 1 diabetes GFR 50 ng/L

Multicenter, placebo-controlled trial of lorcaserin for weight management

Weight loss typically begins within 46 weeks and continues progressively with consistent medication use

In a randomized study of older adults (mean age 67), nightly GHRH administration for 20 weeks significantly increased IGF-1 levels and reduced body fat while improving lean body mass compared with placebo

This is crucial, as oxidative stress can lead to cellular damage and contribute to various chronic diseases